We characterized the molecular mechanism of human αVβ3 integrin inhibition by the candidate therapeutic antibody LM609.
![](http://faculty.washington.edu/dveesler/wordpress/wp-content/uploads/2017/10/LM609_2-2-690x462.jpg)
Structural Biology of Infectious Diseases
We characterized the molecular mechanism of human αVβ3 integrin inhibition by the candidate therapeutic antibody LM609.